FULC Insider Trading Activity and SEC Form 4 Filings
FULC insider trading summary
Over the past 12 months, insiders at Fulcrum Therapeutics, Inc. (FULC) reported 18 sales worth $234.3M by 7 insiders and 12 open-market purchases worth $3.0M by 2 insiders on SEC Form 4. Net insider selling was $231.3M.
Latest FULC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Tang Capital Management LLC | 10% Owner | Buy | $179K (50,945 @ $3.52) |
| Jul 17, 2026 | Kevin Tang | Insider | Buy | $179K (50,945 @ $3.52) |
| Jul 16, 2026 | Kevin Tang | Insider | Buy | $415K (116,671 @ $3.56) |
| Jul 16, 2026 | Tang Capital Management LLC | 10% Owner | Buy | $415K (116,671 @ $3.56) |
| Jul 15, 2026 | Kevin Tang | Insider | Buy | $382K (107,377 @ $3.56) |
| Jul 15, 2026 | Tang Capital Management LLC | 10% Owner | Buy | $382K (107,377 @ $3.56) |
| Jul 14, 2026 | Kevin Tang | Insider | Buy | $272K (75,952 @ $3.58) |
| Jul 14, 2026 | Kevin Tang | Insider | Buy | $191K (53,651 @ $3.56) |
| Jul 14, 2026 | Tang Capital Management LLC | 10% Owner | Buy | $272K (75,952 @ $3.58) |
| Jul 14, 2026 | Tang Capital Management LLC | 10% Owner | Buy | $191K (53,651 @ $3.56) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.